Business
Court Rules Against Importing Gilead Medications
A U.S. appeals court has ruled that companies cannot import Gilead medications from overseas, impacting alternative funding programs.
Coverage timeline — 2 articles
MarketWatch
The “fear of missing out” and “fear of topping out” may drive you to make mistakes.
2026-08-14 16:21 UTC
CNBC
A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.
2026-08-14 16:27 UTC